Advertisement
| 19 June, 2017

Canadian Valeant pharma adds shareholder John Paulson to board

Canadian drugmaker Valeant Pharmaceuticals said it appointed hedge fund manager and billionaire investor John Paulson to its board.

June 19 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals said it appointed hedge fund manager and billionaire investor John Paulson to its board.

Paulson, who heads hedge fund Paulson & Co, is expected to join the board on June 14, the company said on Monday.

Paulson & Co is Valeant's largest shareholder with a 5.68 percent stake as of March 31, according to Reuters data.

(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Saumyadeb Chakrabarty) ((yashaswini.swamynathan@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 2405; Reuters Messaging: yashaswini.swamynathan.thomsonreuters.com@reuters.net))